Evaluation of pharmacokinetic and pharmacodynamic interaction between repaglinide and atazanavir in healthy, diabetic and hepatic impaired rats: possible inhibition of CYP3A, OATP, and P-glycoprotein transporters. ADMET DMPK [Internet]. 2016 Oct. 1 [cited 2025 Nov. 17];4(3):269-7. Available from: https://pub.iapchem.org/ojs/index.php/admet/article/view/328